Streetbeat News

Regulatory

TYGO

Tigo Energy has announced that the United States Patent and Trademark Office (USPTO) has ruled in its favor regarding two petitions previously filed by SMA Solar. This ruling is likely to have a positive impact on Tigo Energy's ability to protect its intellectual property and maintain a competitive edge in the solar technology market.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 2:03 pm

DSS

Impact Biomedical has announced that it has received a U.S. patent allowance for its Laetose technology, which is a low glycemic sugar composition. This development could potentially offer a healthier alternative to traditional sugars, tapping into the growing market for health-conscious food ingredients.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 2:00 pm

TM

Toyota Motor Corporation (NYSE:TM) achieved a record global production of 11.52 million vehicles in 2023, an 8.6% increase from the previous year. Production in Japan rose by 18%, while production outside Japan increased by 3.6%. Total sales for the year were 11.2 million vehicles, a 7.2% year-over-year increase. Despite these positive results, governance issues at Toyota's Daihatsu and Hino Motors units have raised concerns, particularly regarding certification tests for cars and engines. Toyota Chairman Akio Toyoda has apologized for these irregularities. Additionally, Toyota has advised against driving certain vehicles in the U.S. due to the ongoing Takata airbag recalls. TM shares dropped slightly by 0.38% in premarket trading.

Portfolio Pulse from Nabaparna Bhattacharya

January 30, 2024 | 1:59 pm

LEXX

Lexaria Bioscience Corp. has submitted an Investigational New Drug (IND) application to the FDA for a planned Phase 1B clinical trial of its DehydraTECH-CBD product. This submission is a significant step in the drug development process, indicating that Lexaria is progressing towards clinical trials and potential commercialization of its CBD-based therapies.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 1:55 pm

GRI

Trading for GRI was halted and then resumed at 8:55 AM ET, with updated status indicating that quotations have restarted. The news includes information about the resumption times.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 1:55 pm

WKHS

Workhorse Group has been granted three U.S. patents related to its electric delivery vehicles. The patents cover adaptations for electric delivery vehicles, the incorporation of monocoques and modular mold systems, and brake systems for land vehicles. Additionally, a patent for unmanned aerial vehicle delivery systems was also granted.

Portfolio Pulse from Charles Gross

January 30, 2024 | 1:38 pm

SIBN

SI-BONE, Inc. has received FDA 510(k) clearance for a new smaller diameter iFuse Bedrock Granite Implant, which now has an expanded indication and application. This regulatory milestone allows the company to market the product for additional surgical uses, potentially increasing its market share and revenue streams.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 1:38 pm

ICCM

SMCI

UPS

Super Micro Computer (SMCI) reported a strong Q2 with adjusted EPS of $5.59, surpassing the $4.93 estimate, and sales of $3.67B, beating the $3.06B estimate. United Parcel Service (UPS) shares fell after announcing Q4 sales that missed expectations and providing FY24 sales guidance below estimates. IceCure Medical (ICCM) saw a significant increase after the U.S. FDA decided to reopen the De Novo Classification Request for the marketing authorization of ProSense® for early-stage breast cancer.

Portfolio Pulse from ryanfaloona@benzinga.com

January 30, 2024 | 1:38 pm

ICCM

The U.S. FDA has granted IceCure Medical's appeal and has reopened the De Novo classification request for the marketing authorization of ProSense, a treatment for early-stage breast cancer. This decision allows IceCure Medical to potentially move forward with the commercialization of ProSense in the U.S. market.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 1:30 pm

AVRO

Trading for AVRO has resumed at 8:25 AM ET after a temporary halt. The halt status update included news and resumption times for the stock.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 1:25 pm